1. Plagiarism Detection and Prevention
Authors should keep in mind that Ginecologia.ro Magazine participates in the “CrossCheck initiative” for plagiarism detection and prevention. All manuscripts submitted for publication, will be compared to the CrossCheck database using "iThenticate".
iThenticate will generate an overall similarity score and provide a detailed report that highlights sections of duplicated text in the submitted manuscript and links back to the original source(s).
The Editors checks each ‘hit’ in the report to determine its significance. Large sections, or multiple smaller sections, of highly similar text are an immediate red flag; if such sections are a clear indication of deliberate plagiarism or if the duplicated text cannot be removed by careful revision by the author (for example, by extensive rewriting or appropriate referencing) the manuscript will be rejected. If self-plagiarism is detected before a manuscript is accepted for publication, the author is made aware of the offending sections and asked to either cite the original source or to rewrite the duplicated text.
Duplicate submissions will be rejected automatically upon detection.
All submissions must be accompanied by a Declaration of Interest Statement transferring copyright of the manuscript from the author to the publisher and declaring any competing interests. Without this we are legally unable to publish the manuscript. This can be a Cover Letter from the author stating:
a. That the manuscript has been approved by all authors
b. The permission (when required) from the organization/institution to reproduce published material
c. That the manuscript has not been submitted to another journal at the same time or has not already been accepted or published elsewhere.
The authors are responsible for recognizing and disclosing financial and other conflicts of interest related to their study or to the subject of their manuscript. The authors have to acknowledge in the manuscript all financial support for the research work and other financial or personal connections to the work.
Once complete, the Copyright Transfer Agreement should be sent to the Editorial Office along with the rest of the manuscript materials at the time of acceptance or as soon as possible after that (preferably within 24 hours to avoid any delays in processing the manuscript).
3. Statement of Human and Non-human Rights
All research studies, including those involving patients, patient records, research participants or databases, require ethics committee approval (or documented exemption from the Human Subjects Committee).
Authors must follow the ethical standards for human experimentation established in the Declaration of Helsinki (World Medical Association Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277: 925-6). The Editors assume that a manuscript emanating from an institution is submitted with the approval of the requisite authority. The authors of reports of human experimentation that require local institutional approval must have obtained this approval before the experiment was started. Upon request of the Journal Editors, the author(s) must provide copies of the appropriate documentation. Institutional approval must be indicated in the Methods section of the submitted manuscript. If the study is exempt from Institutional Review Board approval, an explanation must be provided.
For reports of experiments on non-human animals or other species, authors must state under Methods section that the guidelines for the care and use of the animals approved by the local institution were followed. The type(s) of non-human animals or other species used in an investigation must be named in the title, abstract, keywords, and methods sections of the manuscript.
For Images in Ginecologia.ro Magazine or similar reports in which the identity of the patient is potentially identifiable, authors must have obtained written permission from the patient(s). The author is responsible for filing this in a secure location. The scope of the consent should allow the author to explicitly disclose the information. Authors must attest to having obtained written consent in the manuscript and must be prepared to provide this documentation upon the Editors’ request.
Trial and research guidelines
Authors must adhere to the following guidelines when formulating the study.
• Randomized controlled trial.
- All Randomized Clinical Trials require registration with clinicaltrials.gov (or other registered authority), prior to enrollment. Both the registration site and registration number must appear on the manuscript title page.
- Authors should consult the updated CONsolidated Standards Of Reporting Trials (CONSORT Statement): Schulz KF, Altman DG, Moher D, CONSORT Group (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 7(3): e1000251. doi:10.1371/journal.pmed.1000251. http://www.consort-statement.org
• Systematic review or metaanalysis. Authors should consult the PRISMA Statement: Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group. Preferred Reporting Items for Systematic reviews and Meta-Analyses: the PRISMA Statement. Ann Intern Med 2009;151:264-9. http://www.prisma-statement.org
• Metaanalysis or systematic review of observational studies. Authors should consult the MOOSE Statement: Stroup DF, Berlin JA, Morton SC, et al, for the Meta-analysis Of Observational Studies in Epidemiology [MOOSE] group. Metaanalysis Of Observational Studies in Epidemiology: a proposal for reporting. JAMA 2000;283:2008-12. http://www.consort-statement.org/resources/downloads/other-instruments
• Diagnostic test(s). Authors should consult STAndards for the Reporting of Diagnostic accuracy studies (STARD Statement): Bossuyt PM, Reitsma JB, Bruns DE, et al, for the STARD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Clin Chem 2003;49:1-6. http://www.stard-statement.org
• Observational study in epidemiology. Authors should consult the STROBE Statement: von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9. http://www.strobe-statement.org or PLoS Med. 2007 Oct 16;4(10):e296. PMID: 17941714
• Health economics. In addition to the general instructions for authors and other guidelines applicable to the study reported in a submitted manuscript (i.e. CONSORT guidelines for a randomized controlled trial), authors of health economics manuscripts should consider address them in the manuscript. http://cdn.elsevier.com/promis_misc/ajoghealth.pdf
The only type of non-clinical research considered must be translational in nature and contain biological implications for obstetrics and gynecology. Additionally, the direct clinical relevance of every submission is considered when an editorial decision is made. Basic science without direct clinical relevance will not be considered.
As many definitions of basic and translational science abound, please see the following translational science examples to assist you in differentiating study types. If uncertain, authors may email an abstract to either editorial office with an inquiry as to whether or not the submission is encouraged. However, this does not guarantee acceptance.
Translational science examples
Clinical Study: an observational cohort study which shows that patients with a subnormal increase in hCG maternal serum concentration are at increased risk for ectopic pregnancy.
Translational Science: proteomic analysis of maternal plasma shows differentially-expressed proteins in patients with ectopic vs. normal pregnancy.
Translational Science: analysis of techniques to enhance the adoption of best practices in caring for women with ectopic pregnancy.
Basic Science: a description of the glycosylation of protein structure of hCG (even if it is based on the purification of hCG from patients with ectopic pregnancies).
Clinical Study: an observational study in which a particular biomarker measured in the mid-trimester increases or decreases the risk for spontaneous preterm labor and delivery.
Translational Science: the transcriptome, proteome, genome, or metabolome of patients who subsequently have spontaneous preterm labor and delivery.
Basic Science: protein sequence of a particular biomarker.